Whilst these discrepancies might be attributed to low power in the paternal analysis (only available in Sweden), this might also suggest that maternal effects involved in the control of fetal growth (including IGF-2 gene expression) also play a role in subsequent offspring cancer risk [49]. The gene discussed is IGF2; the disease is cancer.